Pop Biotechnologies

• Kuang-Yuh Chyu

• Wei-chiao Huang

  Director, vaccine development

Sources: reporter.nih.gov

• National Heart, Lung, and Blood Institute

  R41, Liposome-displayed ApoB fragment for active immunotherapy against atherosclerosis, R41HL184798, US$309.8k, 2026–2027, 31 Jul 2026

• National Institute on Aging

  R42, Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes, R42AG082620, US$822.3k, 2023–2028, 25 Jun 2026

Sources: reporter.nih.gov